Connecting you to content on EBSCOhost

Works matching AU Beguelin, W.

Results: 5

1

Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.

Published in:

Oncogene, 2015, v. 34, n. 26, p. 3413, doi. 10.1038/onc.2014.272

By:

Cordo Russo, R I;
Béguelin, W;
Díaz Flaqué, M C;
Proietti, C J;
Venturutti, L;
Galigniana, N;
Tkach, M;
Guzmán, P;
Roa, J C;
O'Brien, N A;
Charreau, E H;
Schillaci, R;
Elizalde, P V

Publication type:

Article

2

Enhancing T‐cell responses to GCB‐like lymphomas with immune‐checkpoint‐blockade‐based therapies.

Published in:

Hematological Oncology, 2023, v. 41, p. 280, doi. 10.1002/hon.3164_192

By:

Serganova, I.;
Bucktrout, R.;
Isshiki, Y.;
Sarapulov, A.;
Santella, A.;
Rodriguez, M.;
Chakraborty, S.;
Brunschvig, S.;
Qualls, D.;
Vardhana, S.;
Lesokhin, A.;
Melnick, A.;
Beguelin, W.;
Zappasodi, R.

Publication type:

Article

3

EZH2 INHIBITION ENHANCES CAR T ANTITUMOR EFFECT BY INDUCING LYMPHOMA IMMUNOGENICITY AND ENHANCING T CELL FUNCTION.

Published in:

Hematological Oncology, 2023, v. 41, p. 228, doi. 10.1002/hon.3163_149

By:

Isshiki, Y.;
Porazzi, P.;
Melnick, A.;
Ruella, M.;
Béguelin, W.

Publication type:

Article

4

IL10 receptor is a novel therapeutic target in DLBCLs.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1684, doi. 10.1038/leu.2015.57

By:

Béguelin, W;
Sawh, S;
Chambwe, N;
Chan, F C;
Jiang, Y;
Choo, J-W;
Scott, D W;
Chalmers, A;
Geng, H;
Tsikitas, L;
Tam, W;
Bhagat, G;
Gascoyne, R D;
Shaknovich, R

Publication type:

Article

5

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.

Published in:

Oncogene, 2006, v. 25, n. 59, p. 7723, doi. 10.1038/sj.onc.1209757

By:

Salatino, M.;
Beguelin, W.;
Peters, M. G.;
Carnevale, R.;
Proietti, C. J.;
Galigniana, M. D.;
Vedoy, C. G.;
Schillaci, R.;
Charreau, E. H.;
Sogayar, M. C.;
Elizalde, P. V.

Publication type:

Article